Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2024-08-19

JAMP-Mycophenolate 250 mg capsules: Affected lots may contain overweight or underweight capsules

See all recalls from JAMP-Mycophenolate →
Share: Facebook X / Twitter WhatsApp

Recalled Product

JAMP-Mycophenolate 250mg


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. If you are taking this medication, speak with your pharmacist as soon as possible.
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for JAMP-Mycophenolate 250mg →

Hazard / Issue

Product safety

Issued by

Drugs and health products

⚠️ What You Should Do

If you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected by the recall and provide a replacement if needed. Given the capsule format, it is not possible to know whether your capsule is overweight or underweight by looking at it.Continue taking your medication until you speak with your pharmacist, as mycophenolate is an important drug in preventing organ rejection in kidney, heart or liver transplant patients.Contact a health care professional immediately if you or someone you are caring for experience serious side effects.Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.
View official government recall